Form 8-K - Current report:
SEC Accession No. 0001104659-03-026512
Filing Date
2003-11-14
Accepted
2003-11-14 12:16:25
Documents
2
Period of Report
2003-11-14
Items
Item 12: Results of Operations and Financial Condition
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a03-5601_18k.htm 8-K 17420
3 EX-99.1 a03-5601_1ex99d1.htm EX-99.1 96225
  Complete submission text file 0001104659-03-026512.txt   115370
Mailing Address C/O WILSON SONSIN GOODRICH & ROSETI 650 PAGE MILL ROAD PALO ALTO CA 94304
Business Address 150 FIELD DRIVE SUITE 195 LAKE FORREST IL 60045 8472958678
NEOPHARM INC (Filer) CIK: 0000942788 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12493 | Film No.: 031001942
SIC: 2836 Biological Products, (No Diagnostic Substances)